Pharmaceutical and biotech companies often face important decisions about how to protect, exploit and enforce their intellectual property, as well as navigating a market landscape of third party intellectual property. To manage the risks and achieve the best outcomes requires a clear understanding of the science behind each invention, the global prior art and patent landscape, the regulatory position, and the commercial objectives that will guide litigation strategies.
As a firm, we advise on strategies from first filing through to opposition, revocation and infringement actions. We also support clients looking to secure freedom to operate, helping them prepare for launch and enter competitive markets with confidence and a legal strategy.
Our team includes litigation specialists as well as patent attorneys with backgrounds in biochemistry, biology, genetics, chemistry, engineering and other scientific fields. The collaborative approach that comes from working together across departments means that we have the depth and breadth to understand the technical details, the commercial background and the legal implications of each dispute. Our litigation and patent teams work together to provide seamless support during contentious matters, helping clients manage risk and reach the best outcome for their business.
Strategic approaches
Whether enforcing your rights or defending you against challenge, effective litigation strategies rely on understanding how the legal possibilities and commercial plans intersect. We regularly advise on infringement claims, bringing and defending validity challenges and how careful planning can equip you for the best outcome. We are highly familiar with the statutory and inherent jurisdiction of the court, for example in relation to seeking declarations of non-infringement. Similarly, we have guided many pharma companies in relation to the evolving law of Arrow declarations and the factors to be balanced in seeking or resisting interim injunctions.
Contact us to discuss how our team can support your work in the pharma and biotech sectors.
